Home000538 • SHE
Yunnan Baiyao Group Co Ltd
¥56.15
Jan 13, 4:29:45 PM GMT+8 · CNY · SHE · Disclaimer
StockCN listed security
Previous close
¥56.62
Day range
¥55.67 - ¥57.08
Year range
¥44.88 - ¥67.10
Market cap
101.02B CNY
Avg Volume
8.64M
P/E ratio
23.32
Dividend yield
3.09%
Primary exchange
SHE
In the news
Financials
Income Statement
Revenue
Net income
(CNY)Sep 2024Y/Y change
Revenue
9.46B0.86%
Operating expense
1.34B-3.20%
Net income
1.14B-12.16%
Net profit margin
12.03-12.89%
Earnings per share
0.633.28%
EBITDA
1.22B0.81%
Effective tax rate
15.02%
Total assets
Total liabilities
(CNY)Sep 2024Y/Y change
Cash and short-term investments
15.56B16.33%
Total assets
55.61B4.28%
Total liabilities
15.07B12.08%
Total equity
40.54B
Shares outstanding
1.78B
Price to book
2.49
Return on assets
5.29%
Return on capital
7.00%
Net change in cash
(CNY)Sep 2024Y/Y change
Net income
1.14B-12.16%
Cash from operations
811.52M140.35%
Cash from investing
-952.21M-519.49%
Cash from financing
-516.18M-2,102.36%
Net change in cash
-659.43M-221.90%
Free cash flow
-287.03M85.96%
About
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024 state, individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Founded
1902
Employees
8,834
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu